pretomanid
FDA approve new drug for treatment-resistant TB
August 15, 2019Research and Development FDA, TB, US, pharma, pretomanid, tuberculosis
The US FDA has approved BPaL, the TB Alliance’s treatment for drug-resistant tuberculosis (TB). The US regulator gave the go-ahead …
